Cite
HARVARD Citation
Gleeson, M. et al. (2021). Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial. British journal of haematology. pp. 1015-1019. [Online].